Exhibition Review | Raytor Instruments Debuts at the National Pharmaceutical R&D Innovation and Investment M&A Conference —— Deep Insights into Pharmaceutical Industry Needs

From August 14-15, 2025, the National Pharmaceutical R&D Innovation and Investment M&A Conference was successfully held at the Fengda International Hotel in Beijing.

RT6 Automated Dissolution System

RT800 Automated Transdermal Diffusion System

Raytor Instruments showcased its RT6 Automated Dissolution System and RT800 Automated Transdermal Diffusion System at booth K12, attracting numerous industry experts, R&D personnel, and partners for visits and exchanges.

Over the course of two days at the exhibition, the Raytor team engaged in in-depth discussions with experts from multiple fields including pharmaceutical R&D, pharmacy, clinical, and quality control, sharing their experience in applying key technologies such as dissolution testing, semi-solid formulation evaluation, and consistency studies.

Throughout the entire lifecycle of drugs, Raytor instruments continue to play a crucial role.

•During the drug exploration phase, provide data support and optimize experimental protocols.

•In the pharmaceutical and preclinical research phases, ensure the accuracy and reproducibility of experimental results.

•In clinical research and marketing stages, assist in evaluating quality consistency and ensuring regulatory compliance.

In the future, Raytor will continue to uphold the mission of making scientific experiments easier, constantly introducing efficient, precise, and intelligent laboratory solutions, and working with industry partners to drive pharmaceutical innovation.